Skip to main content
HCPCS J8540 · Level II · Part B drug

J8540: dexamethasone, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J8540

Billing unit
0.25 MG
Oral dexamethasone
ASP payment limit
$0.022
October 2026; -15.4% vs July 2026
Practitioner MUE
0
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J8540 is the Level II code for Dexamethasone, oral, 0.25 mg, billed per 0.25 MG. The Medicare Part B ASP payment limit for October 2026 is $0.022 per billing unit, down 15.4% from July 2026. The practitioner MUE allows up to 0 units per date of service (MAI 3). Under OPPS it carries status indicator N. Oral drugs under Part B are payable only in the specific statutory categories (for example oral anticancer or antiemetic drugs with a self-administration exception), so the diagnosis and the regimen must match that category. Other HCPCS codes whose descriptor names dexamethasone: J8541 (Hemady from Edenbridge Pharmaceuticals LLC); J7312 (Ozurdex from Allergan, Inc.; implant and intravitreal route; billed per 0.1 mg); J1096 (Dextenza from Ocular Therapeutix; ophthalmic route; billed per 0.1 mg). The ASP crosswalk maps 49 NDCs to it, sold as Dexamethasone Intensol, Dexamethasone by Hikma Pharmaceuticals USA Inc., Major Pharmaceuticals, PD-Rx Pharmaceuticals, Inc. No current Billing and Coding Article lists J8540, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J8540 at $0.022 per 0.25 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.026 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J8540
QuarterPayment limitPerCoinsurance
October 2026$0.0220.25 MG20%
July 2026$0.0260.25 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 49 NDCs from 10 labelers to J8540. Report the NDC in the claim's drug segment and bill the number of J8540 units that equals the quantity administered divided by 0.25 MG; the last column gives units per full package.

NDCs that crosswalk to J8540
NDCDrug nameLabelerPackage sizeBilling units / package
00054-3176-44Dexamethasone IntensolHikma Pharmaceuticals USA Inc.30 × 1120
00054-3177-63DexamethasoneHikma Pharmaceuticals USA Inc.500 × 1200
00054-4184-25DexamethasoneHikma Pharmaceuticals USA Inc.100 × 11600
00054-8175-25DexamethasoneHikma Pharmaceuticals USA Inc.100 × 11600
00054-8180-25DexamethasoneHikma Pharmaceuticals USA Inc.100 × 1300
00054-8181-25DexamethasoneHikma Pharmaceuticals USA Inc.100 × 1600
00904-7266-61DexamethasoneMajor Pharmaceuticals100 × 11600
00904-7267-61DexamethasoneMajor Pharmaceuticals100 × 12400
00904-7444-61DexamethasoneMajor Pharmaceuticals100 × 1800
43063-0266-07DexamethasonePD-Rx Pharmaceuticals, Inc.7 × 156
50090-0088-04DexamethasoneA-S Medication Solutions6 × 196
50090-0089-00DexamethasoneA-S Medication Solutions28 × 1448
50090-6151-04DexamethasoneA-S Medication Solutions6 × 196
50090-6152-00DexamethasoneA-S Medication Solutions28 × 1448
55289-0582-04DexamethasonePD-Rx Pharmaceuticals, Inc.4 × 164
55289-0582-06DexamethasonePD-Rx Pharmaceuticals, Inc.6 × 196
55289-0582-28DexamethasonePD-Rx Pharmaceuticals, Inc.28 × 1448
55289-0903-12DexamethasonePD-Rx Pharmaceuticals, Inc.12 × 136
60505-6249-01DexamethasoneApotex Corp100 × 1200
60505-6250-01DexamethasoneApotex Corp100 × 1300
60505-6251-01DexamethasoneApotex Corp100 × 1400
60505-6252-01DexamethasoneApotex Corp100 × 1600
60505-6253-01DexamethasoneApotex Corp100 × 1800
60505-6254-01DexamethasoneApotex Corp100 × 11600
60505-6255-01DexamethasoneApotex Corp100 × 12400
60687-0718-01DexamethasoneAmerican Health Packaging100 × 11600
60687-0729-01DexamethasoneAmerican Health Packaging100 × 12400
60687-0773-01DexamethasoneAmerican Health Packaging100 × 1800
66993-0730-02DexamethasonePrasco Laboratories100 × 11600
66993-0730-80DexamethasonePrasco Laboratories100 × 11600
68788-4113-01DexamethasonePreferred Pharmaceuticals Inc12 × 1192
68788-7267-02DexamethasonePreferred Pharmaceuticals Inc21 × 163
68788-7267-03DexamethasonePreferred Pharmaceuticals Inc30 × 190
68788-8223-01DexamethasonePreferred Pharmaceuticals Inc12 × 1192
68788-8223-03DexamethasonePreferred Pharmaceuticals Inc30 × 1480
68788-8223-06DexamethasonePreferred Pharmaceuticals Inc6 × 196
68788-8467-01DexamethasonePreferred Pharmaceuticals Inc12 × 1192
68788-8467-03DexamethasonePreferred Pharmaceuticals Inc30 × 1480
68788-8763-03DexamethasonePreferred Pharmaceuticals Inc30 × 190
68788-8824-03DexamethasonePreferred Pharmaceuticals Inc30 × 1480
70954-0398-10DexamethasoneANI Pharmaceuticals, Inc.100 × 1200
70954-0399-10DexamethasoneANI Pharmaceuticals, Inc.100 × 1300
72603-0187-01DexamethasoneNorthstar RxLLC100 × 1600
72603-0188-01DexamethasoneNorthstar RxLLC100 × 1800
72603-0189-01DexamethasoneNorthstar RxLLC100 × 11600
72603-0190-01DexamethasoneNorthstar RxLLC100 × 12400
72603-0212-01DexamethasoneNorthstar RxLLC100 × 1200
72603-0213-01DexamethasoneNorthstar RxLLC100 × 1300
72789-0501-20DexamethasonePD-Rx Pharmaceuticals, Inc.20 × 160

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J8540. For practitioners the limit is 0 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J8540 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services03 Date of Service Edit: ClinicalOral Medication; Not Payable
Facility outpatient hospital803 Date of Service Edit: ClinicalClinical: Data
DME supplier2163 Date of Service Edit: ClinicalClinical: Society Comment

MUE for J8540 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for J8540 is 48 units for practitioner claims (Medicare: 0). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J8540 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J8540 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J8540 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J8540 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Local coverage policies that list J8540

1 active Local Coverage Determination lists J8540 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J8540 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J8540 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J8540 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J8540

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J8540

What does HCPCS code J8540 describe?

J8540 is defined by CMS as "Dexamethasone, oral, 0.25 mg". Each billing unit represents 0.25 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J8540 a CPT code?

No. J8540 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as dexamethasone; CPT codes are five-character codes maintained by the AMA. On a Part B claim J8540 reports the drug itself in 0.25 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J8540 in October 2026?

The ASP-based payment limit is $0.022 per 0.25 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.026. Commercial payers use their own fee schedules.

How many units of J8540 can be billed per day?

The practitioner Medically Unlikely Edit is 0 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 80. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Oral Medication; Not Payable" as the rationale.

Which NDCs map to J8540?

The October 2026 ASP crosswalk lists 49 NDCs from 10 labelers: Dexamethasone Intensol (Hikma Pharmaceuticals USA Inc.); Dexamethasone (Hikma Pharmaceuticals USA Inc.); Dexamethasone (Major Pharmaceuticals); Dexamethasone (PD-Rx Pharmaceuticals, Inc.). For example NDC 00054-3176-44 (package size 30) equals 120 billing units of J8540.

Does J8540 have NCCI bundling edits?

No active practitioner PTP pairs list J8540 as a column-1 or column-2 code in the v323r0 release.

J8540 vs J8541: what is the difference?

Both are HCPCS Level II codes whose descriptor names dexamethasone. What sets J8541 apart: Hemady from Edenbridge Pharmaceuticals LLC. J8540 is billed per 0.25 mg, limit $0.022, MUE 0; J8541 is billed per 0.25 mg, limit $0.375. Report the code whose descriptor matches the product and setting in the record.

J8540 vs J7312: what is the difference?

Both are HCPCS Level II codes whose descriptor names dexamethasone. What sets J7312 apart: Ozurdex from Allergan, Inc.; implant and intravitreal route; billed per 0.1 mg. J8540 is billed per 0.25 mg, limit $0.022, MUE 0; J7312 is billed per 0.1 mg, limit $202.424, MUE 14. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.